Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04559061 · ClinicalTrials.gov registry record
Vektor vMap™ Clinical Validation Study
A clinical trial, sponsored by Vektor Medical.
- Completed
- Registry status
- 225
- Enrollment target
NCT04559061 is a clinical trial that has completed, run by Vektor Medical. The registered enrollment target is 225 participants.
The verdict
NCT04559061 has completed, sponsored by Vektor Medical.
- COMPLETED
- Registry status
- 225 participants
- Enrollment target
Study Summary
This is a retrospective, multi center clinical study collecting existing, de-identified subject data from medical records to be analyzed using an independent core laboratory to validate performance of a computational ECG mapping system (vMap™).
Interventions
- DEVICE Cardiac ablation procedure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 225 participants |
| Start Date | 2020-12-01 |
| Est. Completion | 2021-04-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04559061
The ClinicalTrials.gov registry entry for NCT04559061 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 225 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vektor Medical, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cardiac ablation procedure is the first listed.
NCT04559061 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04559061 about?
NCT04559061 is a clinical study titled "Vektor vMap™ Clinical Validation Study". This is a retrospective, multi center clinical study collecting existing, de-identified subject data from medical records to be analyzed using an independent core laboratory to validate performance of a computational ECG mapping system (vMap™).
What is the current status of trial NCT04559061?
This trial is currently completed. The enrollment target is 225 participants. The study started on 2020-12-01. Estimated completion is 2021-04-06.
What interventions are being tested in trial NCT04559061?
The interventions under investigation include: Cardiac ablation procedure (DEVICE).
Who is sponsoring clinical trial NCT04559061?
This trial is sponsored by Vektor Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.